Detalhe da pesquisa
1.
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.
Proc Natl Acad Sci U S A
; 108(19): 7938-43, 2011 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21518860
2.
Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
J Autoimmun
; 47: 83-93, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24090977
3.
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta.
J Immunol
; 183(4): 2232-41, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19635906
4.
Controlled release of monoclonal antibodies from poly-l-lysine-coated alginate spheres within a scaffolded implant mitigates autoimmune responses to transplanted islets and limits systemic antibody toxicity.
Mater Sci Eng C Mater Biol Appl
; 93: 390-398, 2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30274071
5.
Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft.
Cell Transplant
; 27(3): 531-541, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756517
6.
Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis.
J Clin Invest
; 125(10): 3928-40, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26368307
7.
IL-10 induction from implants delivering pancreatic islets and hyaluronan.
J Diabetes Res
; 2013: 342479, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23971054
8.
Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor.
Cell Transplant
; 21(10): 2099-110, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23231959